These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20195613)

  • 1. [Modeling in value-based medicine].
    Neubauer AS; Hirneiss C; Kampik A
    Ophthalmologe; 2010 Mar; 107(3):228-34. PubMed ID: 20195613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patient-reported and patient-weighted outcomes in ophthalmology].
    Scheibler F; Finger RP; Grosselfinger R; Dintsios CM
    Ophthalmologe; 2010 Mar; 107(3):235-40. PubMed ID: 20024566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value-based medicine in ophthalmology].
    Finger RP
    Ophthalmologe; 2010 Mar; 107(3):213. PubMed ID: 20024565
    [No Abstract]   [Full Text] [Related]  

  • 4. [Value-based medicine for glaucoma].
    Hirneiss C; Kampik A; Neubauer AS
    Ophthalmologe; 2010 Mar; 107(3):223-7. PubMed ID: 20182735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value-based medicine in ophthalmology].
    Hirneiss C; Neubauer AS; Tribus C; Kampik A
    Ophthalmologe; 2006 Jun; 103(6):493-500. PubMed ID: 16763866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Markov model and discrete-event simulation techniques for HIV.
    Simpson KN; Strassburger A; Jones WJ; Dietz B; Rajagopalan R
    Pharmacoeconomics; 2009; 27(2):159-65. PubMed ID: 19254048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decision-analytical modelling of costs per QALY in the context of the German Social Law].
    Rogowski WH; Landauer M; John J
    Gesundheitswesen; 2009 Nov; 71(11):739-50. PubMed ID: 19551622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
    Siebert U; Rochau U; Claxton K
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies.
    Barbosa C; Dowd WN; Zarkin G
    Value Health; 2020 Aug; 23(8):1096-1108. PubMed ID: 32828223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation.
    Riley P; Glenny AM; Worthington HV; Jacobsen E; Robertson C; Durham J; Davies S; Petersen H; Boyers D
    Health Technol Assess; 2020 Feb; 24(7):1-224. PubMed ID: 32065109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for Germany.
    Berger K; Schopohl D; Eheberg D; Auerswald G; Kurnik K; Schramm W
    Klin Padiatr; 2013 May; 225(3):152-8. PubMed ID: 23519749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of evidence in economic decision models: practical issues and methodological challenges.
    Cooper NJ; Sutton AJ; Ades AE; Paisley S; Jones DR;
    Health Econ; 2007 Dec; 16(12):1277-86. PubMed ID: 18034447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating information about cost-effectiveness into evidence-based decision-making: the evidence-based practice center (EPC) model.
    Helfand M
    Med Care; 2005 Jul; 43(7 Suppl):33-43. PubMed ID: 16056007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
    Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
    Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Level Modeling Approach Using Discrete-Event Simulation: A Cost-Effectiveness Study of Current Treatment Guidelines for Women with Postmenopausal Osteoporosis.
    Le QA
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1089-1095. PubMed ID: 31556816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.